Infinity Pharmaceuticals | INFI - Net Income


Infinity Pharmaceuticals reported $-9.96M in Net Income for its fiscal quarter ending in June of 2023.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Alterity Therapeutics Limited AUD -5.77M 2.26M Jun/2023
Amgen USD 1.33B 1.88B Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -6.98M 360K Sep/2025
CSL USD 497.5M 1.51B Jun/2025
Eisai JPY 17.18B 7.02B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Grifols EUR 148.4M 15.76M Sep/2025
Incyte USD 299.28M 124.89M Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
J&J USD 5.12B 36M Dec/2025
Novartis USD 3.93B 96M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
TG Therapeutics USD 390.9M 362.71M Sep/2025